Harry Kleanthous
Corporate Officer/Principal bei SK BIOSCIENCE CO.,LTD.
Aktive Positionen von Harry Kleanthous
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SK BIOSCIENCE CO.,LTD. | Corporate Officer/Principal | 21.10.2022 | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - | - |
Karriereverlauf von Harry Kleanthous
Ausbildung von Harry Kleanthous
| University of London | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Südkorea | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SK BIOSCIENCE CO.,LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
- Börse
- Insiders
- Harry Kleanthous
- Erfahrung
